2022 - Research.com Best Female Scientist Award
Her scientific interests lie mostly in Internal medicine, Breast cancer, Body mass index, Overweight and Endocrinology. The Internal medicine study which covers Oncology that intersects with Weight gain. Her Breast cancer study combines topics from a wide range of disciplines, such as Prospective cohort study, Gynecology and Risk factor.
In her research, Hormone is intimately related to Randomized controlled trial, which falls under the overarching field of Body mass index. While the research belongs to areas of Overweight, Anne McTiernan spends her time largely on the problem of Weight loss, intersecting her research to questions surrounding VO2 max. Her Endocrinology research is multidisciplinary, relying on both Immune system and Physiology.
Anne McTiernan focuses on Internal medicine, Breast cancer, Endocrinology, Cancer and Overweight. Her research investigates the connection between Internal medicine and topics such as Oncology that intersect with problems in Epidemiology. Anne McTiernan combines subjects such as Hazard ratio, Prospective cohort study, Gynecology and Risk factor with her study of Breast cancer.
Her work deals with themes such as Gastroenterology, Surgery and Family medicine, which intersect with Cancer. Her Overweight study is concerned with Obesity in general. Her research in Randomized controlled trial tackles topics such as Physical therapy which are related to areas like Quality of life.
Anne McTiernan mostly deals with Internal medicine, Breast cancer, Endocrinology, Weight loss and Cancer. Her research links Oncology with Internal medicine. Her work in Breast cancer tackles topics such as Psychological intervention which are related to areas like Lower risk.
Anne McTiernan has researched Weight loss in several fields, including Estrone, Overweight, Randomized controlled trial, Lean body mass and Vitamin D and neurology. Her research in Overweight intersects with topics in Sex hormone-binding globulin and Hormone therapy. Her Cancer research is multidisciplinary, incorporating elements of Weight gain, Quality of life, Weight change and Risk factor.
Her primary areas of study are Internal medicine, Breast cancer, Endocrinology, Weight loss and Overweight. Her is doing research in Body mass index, Adiponectin, Confidence interval, Hazard ratio and Hormone replacement therapy, both of which are found in Internal medicine. Her Breast cancer study combines topics in areas such as Hormone, Estrogen, Oncology and Physiology.
Her Endocrinology study integrates concerns from other disciplines, such as Epidemiology of cancer and Gerontology. Her Weight loss research includes themes of Vitamin D and neurology, Placebo and Randomized controlled trial. In her study, which falls under the umbrella issue of Overweight, Obesity is strongly linked to Aerobic exercise.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Influence of Estrogen Plus Progestin on Breast Cancer and Mammography in Healthy Postmenopausal Women: The Women's Health Initiative Randomized Trial
Rowan T. Chlebowski;Susan L. Hendrix;Robert D. Langer;Marcia L. Stefanick.
JAMA (2003)
Design of the Women's Health Initiative clinical trial and observational study
G. Anderson;S. Cummings;L. S. Freedman;C. Furberg.
Controlled Clinical Trials (1998)
American Cancer Society Guidelines on Nutrition and Physical Activity for Cancer Prevention: Reducing the Risk of Cancer with Healthy Food Choices and Physical Activity
Lawrence H. Kushi;Tim Byers;Colleen Doyle;Elisa V. Bandera.
CA: A Cancer Journal for Clinicians (2002)
Pelvic organ prolapse in the Women's Health Initiative: gravity and gravidity.
Susan L. Hendrix;Amanda Clark;Ingrid Nygaard;Aaron Aragaki.
American Journal of Obstetrics and Gynecology (2002)
Effects of aerobic exercise on mild cognitive impairment: a controlled trial.
Laura D. Baker;Laura L. Frank;Karen Foster-Schubert;Pattie S. Green.
JAMA Neurology (2010)
Recommendations for follow-up care of individuals with an inherited predisposition to Cancer. II. BRCA1 and BRCA2
Wylie Burke;Mary Daly;Judy Garber;Jeffrey Botkin.
JAMA (1997)
Exemestane for Breast-Cancer Prevention in Postmenopausal Women
Paul E. Goss;James N. Ingle;José E. Alés-Martínez;Angela M. Cheung.
The New England Journal of Medicine (2011)
Recommendations for follow-up care of individuals with an inherited predisposition to cancer. II. BRCA1 and BRCA2. Cancer Genetics Studies Consortium
W Burke;M Daly;J Garber;J Botkin.
JAMA (1997)
Body mass index and survival in women with breast cancer—systematic literature review and meta-analysis of 82 follow-up studies
D. S.M. Chan;A. R. Vieira;D. Aune;D. Aune;E. V. Bandera.
Annals of Oncology (2014)
Physical Activity, Biomarkers, and Disease Outcomes in Cancer Survivors: A Systematic Review
Rachel Ballard-Barbash;Christine M. Friedenreich;Kerry S. Courneya;Sameer M. Siddiqi.
Journal of the National Cancer Institute (2012)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:
University of Utah
Fred Hutchinson Cancer Research Center
National Institutes of Health
University of Alberta
UCLA Medical Center
Harvard University
University of Washington
Fred Hutchinson Cancer Research Center
University of Southern California
Harvard Medical School
Purdue University West Lafayette
Hunan University
University of Michigan–Ann Arbor
Ikerbasque
Centre national de la recherche scientifique, CNRS
University College Cork
Chang Gung University
University of Ottawa
Government of the United Kingdom
University of Colorado Denver
The University of Texas at Austin
Children's Hospital of Philadelphia
Duke University
University of Debrecen
Rio de Janeiro State University
Herzberg Institute of Astrophysics